Thomas Englese
Direktor/Vorstandsmitglied bei Therakos (UK) Ltd.
Profil
Thomas Joseph Englese is currently a Director at Therakos (UK) Ltd.
He was previously a Senior Director-Business Operations at Baxter International, Inc. and a Vice President-Customer Operations at Ikaria, Inc. He also served as the General Manager-North America Hospital Therapies at Mallinckrodt Plc.
Englese holds an MBA from The Pennsylvania State University and an undergraduate degree from Villanova University.
He is also the Chief Commercial Officer at Elutia, Inc.
Aktive Positionen von Thomas Englese
| Unternehmen | Position | Beginn |
|---|---|---|
Therakos (UK) Ltd.
 Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Founded in 2012, Therakos (UK) Ltd. is a subsidiary of Mallinckrodt Plc. The company is based in Staines-upon-Thames, UK. The British company develops immune cell therapies that are delivered through extracorporeal photopheresis. | Direktor/Vorstandsmitglied | 30.10.2015 |
Ehemalige bekannte Positionen von Thomas Englese
| Unternehmen | Position | Ende |
|---|---|---|
| MALLINCKRODT PLC | Corporate Officer/Principal | 01.07.2019 |
| IKARIA, INC. | Corporate Officer/Principal | 01.03.2015 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.2008 |
| ELUTIA INC. | Corporate Officer/Principal | - |
Ausbildung von Thomas Englese
| The Pennsylvania State University | Masters Business Admin |
| Villanova University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELUTIA INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Therakos (UK) Ltd.
Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Founded in 2012, Therakos (UK) Ltd. is a subsidiary of Mallinckrodt Plc. The company is based in Staines-upon-Thames, UK. The British company develops immune cell therapies that are delivered through extracorporeal photopheresis. | Health Services |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
